Frazier Life Sciences Management’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $93.9M | Hold |
|
|||||
|
2025
Q2 | $56.1M | Hold |
|
|||||
|
2025
Q1 | $64.5M | Sell |
|
|||||
|
2024
Q4 | $43.9M | Buy |
|
|||||
|
2024
Q3 | $24.7M | Hold |
|
|||||
|
2024
Q2 | $22M | Hold |
|
|||||
|
2024
Q1 | $25.5M | Hold |
|
|||||
|
2023
Q4 | $9.89M | Buy |
|
|||||
|
2023
Q3 | $15M | Hold |
|
|||||
|
2023
Q2 | $16.4M | Buy |
|
|||||
|
2023
Q1 | $12.3M | Hold |
|
|||||
|
2022
Q4 | $12.9M | Buy |
|
|||||
|
2022
Q3 | $8.32M | Buy |
|
|||||
|
2022
Q2 | $3.29M | Buy |
|